for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Option Care Health Inc

BIOS.OQ

Latest Trade

3.46USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

1.56

 - 

4.14

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
3.46
Open
--
Volume
--
3M AVG Volume
22.63
Today's High
--
Today's Low
--
52 Week High
4.14
52 Week Low
1.56
Shares Out (MIL)
699.64
Market Cap (MIL)
2,445.23
Forward P/E
-33.90
Dividend (Yield %)
--

Next Event

Q3 2019 BioScrip Inc Earnings Release

Latest Developments

More

BioScrip Announces Shareholder Approval Of Merger With Option Care

BioScrip Reports Qtrly Loss Per Share $0.14

Bioscrip Reports First Quarter 2019 Financial Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Option Care Health Inc

Option Care Health, Inc., formerly BioScrip, Inc., incorporated on March 22, 1996, provides home and alternate site infusion services in the United States. The Company provides a range of infusion therapies to patients. It provides care for patients with acute and chronic conditions. Its therapeutic services include anti-infective, Option Care Women’s health, bleeding disorders, heart failure, immunoglobulin, nutrition support, chronic inflammatory disorders and specialized therapies. Its other services include hemophilia care, transplant and pediatrics.

Industry

Healthcare Facilities

Contact Info

3000 Lakeside Dr Ste 300N

+1.312.9402443

https://www.bioscrip.com/

Executive Leadership

Harry M. Jansen Kraemer

Independent Chairman of the Board

John Charles Rademacher

President, Chief Executive Officer, Director

Michael H Shapiro

Chief Financial Officer

Harriet Booker

Chief Operating Officer, Senior Vice President

Robert R. Kampstra

Chief Accounting Officer

Key Stats

1.60 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.9K

2017

0.8K

2018

0.7K

2019(E)

1.6K
EPS (USD)

2016

-0.540

2017

-0.580

2018

-0.490

2019(E)

-0.100
Price To Earnings (TTM)
--
Price To Sales (TTM)
3.33
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-9.90
Return on Equity (TTM)
-8.22

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up